C Y Francis1, J Morris, P J Whorwell. 1. Department of Medicine, University Hospital of South Manchester, West Didsbury, UK.
Abstract
BACKGROUND: The clinical assessment and investigation of irritable bowel syndrome would be greatly facilitated by the introduction of a simple, easy to use severity scoring system. Such a system, developed in our department over a number of years, has been submitted to validation in a total of 141 patients and 40 healthy controls. METHODS: The system, incorporating pain, distension, bowel dysfunction and quality of life/global well-being, was assessed for its ability to reliably score patients previously classified as mild, moderate or severe. The reproducibility and sensitivity to change of the system was also assessed. RESULTS: The maximum achievable score was 500. Mild, moderate and severe cases were indicated by scores of 75 to 175, 175 to 300 and > 300 respectively. Controls scored below 75 and patients scoring in this range can be considered to be in remission. There was a highly significant difference between controls and patients as a whole (P = 0.0001) as well as significant differences (P < 0.01) between all severity categories. Scores repeated within 24 h were very reproducible and sensitivity to change was also extremely good (P < 0.001) with a change of 50 reliably indicating improvement. CONCLUSION: These results suggest that this scoring system should prove to be a valuable instrument in helping to meet the many challenges offered by irritable bowel syndrome.
BACKGROUND: The clinical assessment and investigation of irritable bowel syndrome would be greatly facilitated by the introduction of a simple, easy to use severity scoring system. Such a system, developed in our department over a number of years, has been submitted to validation in a total of 141 patients and 40 healthy controls. METHODS: The system, incorporating pain, distension, bowel dysfunction and quality of life/global well-being, was assessed for its ability to reliably score patients previously classified as mild, moderate or severe. The reproducibility and sensitivity to change of the system was also assessed. RESULTS: The maximum achievable score was 500. Mild, moderate and severe cases were indicated by scores of 75 to 175, 175 to 300 and > 300 respectively. Controls scored below 75 and patients scoring in this range can be considered to be in remission. There was a highly significant difference between controls and patients as a whole (P = 0.0001) as well as significant differences (P < 0.01) between all severity categories. Scores repeated within 24 h were very reproducible and sensitivity to change was also extremely good (P < 0.001) with a change of 50 reliably indicating improvement. CONCLUSION: These results suggest that this scoring system should prove to be a valuable instrument in helping to meet the many challenges offered by irritable bowel syndrome.
Authors: Ravi Karkar; Jessica Schroeder; Daniel A Epstein; Laura R Pina; Jeffrey Scofield; James Fogarty; Julie A Kientz; Sean A Munson; Roger Vilardaga; Jasmine Zia Journal: Proc SIGCHI Conf Hum Factor Comput Syst Date: 2017-05-02
Authors: Jeannie S Huang; Laura Terrones; Alan N Simmons; Walter Kaye; Irina Strigo Journal: J Pediatr Gastroenterol Nutr Date: 2016-11 Impact factor: 2.839
Authors: Hannah J Holmes; Elyse R Thakur; Jennifer N Carty; Maisa S Ziadni; Heather K Doherty; Nancy A Lockhart; Howard Schubiner; Mark A Lumley Journal: Gen Hosp Psychiatry Date: 2018-05-03 Impact factor: 3.238
Authors: Barbara L Robinson; Catherine A Matthews; Olafur S Palsson; Elizabeth Geller; Marsha Turner; Brent Parnell; Andrea Crane; Mary Jannelli; Ellen Wells; Annamarie Connolly; Feng-Chang Lin; William E Whitehead Journal: Female Pelvic Med Reconstr Surg Date: 2013 Jan-Feb Impact factor: 2.091
Authors: M Bellini; D Gambaccini; L Bazzichi; G Bassotti; M G Mumolo; B Fani; F Costa; A Ricchiuti; N De Bortoli; M Mosca; S Marchi; A Rossi Journal: Tech Coloproctol Date: 2017-05-31 Impact factor: 3.781
Authors: Miranda A L van Tilburg; Olafur S Palsson; Yehuda Ringel; William E Whitehead Journal: Complement Ther Med Date: 2014-01-08 Impact factor: 2.446